Former MGI Pharma management team is running the private company, Tesaro, which has licensed a castoff drug from MRK and is planning an IPO: http://www.forbes.com/sites/matthewherper/2012/06/06/biotech-all-stars-buy-castoff-experimental-merck-cancer-drug/